pharma news today glp-1 2025 Novo cuts prices 70%, but semaglutide revenue could grow in 2026 GLP1 agonists set to become
Description
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for diabetes and obesity, exhibit pleiotropic effectsincluding anti-inflammatory, antioxidant, and neuroprotective propertiesthat position them as transformative candidates ...
Prescription Delivered to Your Door
He notes that while weight loss medication is "appropriate for some patients," it is not suitable for allwith the GLP-1 being recommended on a case-by-case basis
Publix now offers a GLP-1 brochure to help you find food and other items throughout the store to support your weight-loss journey.
